Skip to main content
. 2018 Oct 26;97(43):e12843. doi: 10.1097/MD.0000000000012843

Figure 3.

Figure 3

Forest plot: relative risks on urinary tract infection (UTI) of empagliflozin (EMPA) on type 2 diabetes mellitus.